Star Equity Holdings Inc
NASDAQ:STRR
Star Equity Holdings Inc
Cash Equivalents
Star Equity Holdings Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Star Equity Holdings Inc
NASDAQ:STRR
|
Cash Equivalents
$18.3m
|
CAGR 3-Years
79%
|
CAGR 5-Years
65%
|
CAGR 10-Years
0%
|
|
DaVita Inc
NYSE:DVA
|
Cash Equivalents
$345.1m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-11%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash Equivalents
$474m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Cash Equivalents
$9.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Cash Equivalents
$8.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash Equivalents
$99.3m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-12%
|
See Also
What is Star Equity Holdings Inc's Cash Equivalents?
Cash Equivalents
18.3m
USD
Based on the financial report for Dec 31, 2023, Star Equity Holdings Inc's Cash Equivalents amounts to 18.3m USD.
What is Star Equity Holdings Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
0%
Over the last year, the Cash Equivalents growth was 290%. The average annual Cash Equivalents growth rates for Star Equity Holdings Inc have been 79% over the past three years , 65% over the past five years .